Emcure Pharma IPO: All you need to know
[email protected]28 Oct, 2021News
Founded in 1983, Emcure Pharmaceuticals manufactures and globally markets a wide variety of pharmaceutical products. It has filed its draft red herring prospectus (DRHP) with the Securities Exchange Board of India (SEBI) to raise funds through an IPO (initial public offering). The company is aiming to raise ?4,000 crore through this IPO. The Pune-based company is the 12th largest pharmaceutical company in India. As per the CRISIL report FY21, Emcure Pharmaceutical Limited is a leader (as per sales numbers) in three therapeutic areas: gynaecology, blood-related and HIV antivirals.
Related Bookmarks
- Gennova MRNA-Based Vaccine Awaits Nod
- Emcure Pharma Files DRHP For IPO
- Magento Connector to Microsoft Dynamics 365 Business Central ERP | i95Dev
- The Advantages of Using a Real Estate Agent When Purchasing a Home
- "How BigCommerce NAV Integration Leads to Business Growth "
- BigCommerce Integration with Business Central | i95Dev
- Causes for the Error Codes on Canon Printers
- Google�s $599 Pixel 6 Has A Bigger Stance Than All Other High End Smartphones?
- The Basics of an MOT Test
- Things You Should Know About Full Home Renovation in Toronto
Recent Profiles
Austin Lit
B52club
Glp Shampoo
Juicy Bar 25000
Lions Tigers & Bears Sanctuary
Ball88
Sal Psychiatry Services
Socolive
Jl16
F168